Skip Navigation LinksHome > August 2014 - Volume 35 - Issue 8 > Nuclear medicine in the management of patients with heart fa...
Nuclear Medicine Communications:
doi: 10.1097/MNM.0000000000000143
Review Articles

Nuclear medicine in the management of patients with heart failure: guidance from an expert panel of the International Atomic Energy Agency (IAEA)

Peix, Amaliab; Mesquita, Claudio Tinococ; Paez, Dianaa; Pereira, Carlos Cunhad; Felix, Renatae; Gutierrez, Claudiag; Jaimovich, Rodrigoi; Ianni, Barbara Mariaf; Soares, Jose Jrf; Olaya, Pastorh; Rodriguez, Ma. Victoriaj; Flotats, Albertk; Giubbini, Raffaelel; Travin, Markm; Garcia, Ernest V.n

Open Access
Collapse Box

Abstract

Heart failure is increasing worldwide at epidemic proportions, resulting in considerable disability, mortality, and increase in healthcare costs. Gated myocardial perfusion single photon emission computed tomography or PET imaging is the most prominent imaging modality capable of providing information on global and regional ventricular function, the presence of intraventricular synchronism, myocardial perfusion, and viability on the same test. In addition, 123I-mIBG scintigraphy is the only imaging technique approved by various regulatory agencies able to provide information regarding the adrenergic function of the heart. Therefore, both myocardial perfusion and adrenergic imaging are useful tools in the workup and management of heart failure patients. This guide is intended to reinforce the information on the use of nuclear cardiology techniques for the assessment of heart failure and associated myocardial disease.

© 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.